BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4330217)

  • 1. Metastatic adrenal cortical carcinoma: biochemical changes accompanying clinical regression during therapy with o,p'-DDD.
    Helson L; Wollner N; Murphy ML; Schwartz MK
    Clin Chem; 1971 Dec; 17(12):1191-3. PubMed ID: 4330217
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of adrenocortical cancer treated with O,P'-DDD.
    Sakauchi N; Kumaoka S; Naruke T; Abe O; Kusama M
    Endocrinol Jpn; 1969 Apr; 16(2):287-90. PubMed ID: 5819718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Masculinizing tumors of the adrenal cortex in children before puberty].
    Decourt J; Anoussakis C
    Sem Hop; 1969 Mar; 45(13):817-26. PubMed ID: 4327255
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroids in urine from a patient with adrenocortical carcinoma after treatment with op'-DDD.
    Gustafsson JA; Lisboa BP
    Steroidologia; 1971; 2(1):27-37. PubMed ID: 5133742
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion of virilization to feminization in a young girl with adrenal cortical carcinoma.
    Halmi KA; Lascari AD
    Cancer; 1971 Apr; 27(4):931-5. PubMed ID: 5574080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with o,p'-DDD of inoperable forms of malignant adrenal gland neoplasms].
    Perevodchikova NI; Platinskiĭ LV; Kertsman VI
    Vopr Onkol; 1972; 18(11):24-9. PubMed ID: 4645074
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience with o,p'-DDD in the treatment of hypercorticism].
    Mathieu De Fossey B; Luton JP; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(1):93-102. PubMed ID: 4872638
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of o.p' DDD to the case of adrenal cortex cancer].
    Naruse T; Sasaki T; Yamaoka T; Matsuoka K; Nekita H
    Horumon To Rinsho; 1970 Mar; 18(3):241-4. PubMed ID: 5464572
    [No Abstract]   [Full Text] [Related]  

  • 9. Virilizing adrenal tumor in a child suppressed with dexamethasone for three years. Effect of o,p'-DDD on serum and urinary androgens.
    Korth-Schutz S; Levine LS; Roth JA; Saenger P; New MI
    J Clin Endocrinol Metab; 1977 Mar; 44(3):433-9. PubMed ID: 138687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and androstenedione production rates in patients with metastatic adrenal cortical carcinoma.
    Bardin CW; Lipsett MB; French AM
    J Clin Endocrinol Metab; 1968 Feb; 28(2):215-20. PubMed ID: 5636152
    [No Abstract]   [Full Text] [Related]  

  • 11. Virilizing tumors of the adrenal cortex.
    Kenny FM; Hashida Y; Askari HA; Sieber WH; Fetterman GH
    Am J Dis Child; 1968 Apr; 115(4):445-58. PubMed ID: 4230595
    [No Abstract]   [Full Text] [Related]  

  • 12. Dexamethasone-suppressible adrenocortical tumor.
    Kendall JW; Sloop PR
    N Engl J Med; 1968 Sep; 279(10):532-5. PubMed ID: 4299556
    [No Abstract]   [Full Text] [Related]  

  • 13. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 15. AN EFFECT OF O,P'-DDD ON THE EXTRA-ADRENAL METABOLISM OF CORTISOL IN MAN.
    BLEDSOE T; ISLAND DP; NEY RL; LIDDLE GW
    J Clin Endocrinol Metab; 1964 Dec; 24():1303-11. PubMed ID: 14243174
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenal cortical carcinoma. Clinical features of 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):572-80. PubMed ID: 5923598
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carcinoma of the adrenal cortex].
    Dzhurin DS; Michin IV; Popovich S; Manoĭlovich DL; Dzhordzhevich P
    Probl Endokrinol (Mosk); 1974; 20(3):51-6. PubMed ID: 4375811
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperpigmentation on cortisone after adrenalectomy for primary aldosteronism.
    Lawrence GD; Bravo E; Bartter FC
    Arch Intern Med; 1974 Oct; 134(4):734-7. PubMed ID: 4370079
    [No Abstract]   [Full Text] [Related]  

  • 19. [Enzyme and hormone studies in a virilising adrenal cortex tumor].
    Dahm K; Bayer JM; Breuer H
    Klin Wochenschr; 1968 May; 46(10):520-6. PubMed ID: 5699104
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of androgens and their precursors in adrenocortical virilizing carcinoma.
    Saez JM; Loras B; Morera AM; Bertrand J
    J Clin Endocrinol Metab; 1971 Apr; 32(4):462-9. PubMed ID: 4251155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.